Dr Reddy’s receives Emergency Use Authorisation for molnupiravir

The company will market it under the brand name Molflu

Aurobindo to manufacture and market molnupiravir

The drug will be marketed under the brand name Molnaflu

Cipla receives EUA for Cipmolnu

The Subject Expert Committee (SEC), on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended granting permission to manufacture and market anti-Covid pill molnupiravir for restricted emergency use

Sun Pharma receives DCGI approval for Molxvir in India

The product is expected to be available in a week’s time

Granules India appoints Sucharita Rao Palepu as Non-executive Independent Director

Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis

Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000

WHO grants EUL for Covovax

First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine

Six benefits of Cloud Computing in the pharma industry

Fullife Healthcare raises US $ 22 mn in Series C funding

This round of funding will support Fast&Up and Chicnutrix to expand their domestic presence, enhance manufacturing capabilities and accelerate momentum globally

Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA

During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests